Moleculin Biotech (MBRX) Reports Q3 Loss of $0.12/Share
Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.